Sernova (TSE:SVA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sernova Corp, a biotech firm advancing cell therapies for chronic diseases, appoints Jonathan Rigby as Executive Chairman to bolster capital market efforts and company growth. The leadership shuffle, marked by the resignation of former Chairman Brett Whalen, signals a strategic move to enhance Sernova’s market presence. Rigby, with a successful track record in biotech ventures, pledges to leverage his experience to propel the company and aid individuals like himself affected by Type 1 Diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
